Cogent Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COGT and other ETFs, options, and stocks.

About COGT

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17.

CEO

Andrew R. Robbins

CEOAndrew R. Robbins

Employees

205

Employees205

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2014

Founded2014

Employees

205

Employees205

COGT Key Statistics

Market cap

1.73B

Market cap1.73B

Price-Earnings ratio

-5.10

Price-Earnings ratio-5.10

Dividend yield

—

Dividend yield—

Average volume

1.82M

Average volume1.82M

High today

—

High today—

Low today

—

Low today—

Open price

$12.68

Open price$12.68

Volume

0.00

Volume0.00

52 Week high

$13.50

52 Week high$13.50

52 Week low

$3.72

52 Week low$3.72

Analyst ratings

75%

of 12 ratings

Buy

75%

Hold

25%

Sell

People also own

Based on the portfolios of people who own COGT. This list is generated using Robinhood data, and it’s not a recommendation.

KalVista Pharmaceuticals